The Philadelphia Phillies entered the final days before the Aug. 3 trade deadline with a clear sense of what a transformative addition in the outfield could look like.
Minnesota Twins star Byron Buxton has long represented the ideal match: a right-handed power bat who can patrol center field at an elite level, signed through 2028 at a manageable rate, and capable of slotting into a lineup already featuring Bryce Harper, Kyle Schwarber and Brandon Marsh.
Reports over the past year, including recent suggestions that Buxton had once indicated a willingness to waive his no-trade clause for a move to Philadelphia, kept the possibility alive even as Minnesota’s front office repeatedly downplayed any interest in dealing their star.
That calculus changed sharply on Wednesday when the Twins placed Buxton on the 10-day injured list with a right hip impingement. The injury is not new. It has lingered in some form since May, and Buxton had only just returned from the injured list on July 20. In the seven games that followed, he managed just four singles in 27 plate appearances, looking limited and producing a .160/.222/.160 line.
The Twins removed him from Tuesday’s contest against the Royals with renewed hip soreness, confirming a re-aggravation of the same issue.
From the Phillies’ perspective, this development introduces layers of risk that make any potential deal far more complicated than it already was. Buxton’s career has been defined by extraordinary talent interrupted by frequent injuries, and he has not appeared in more than 126 games in a season since 2017.
Acquiring a player who has already shown he cannot stay healthy long enough to sustain production through a full stretch run, let alone October, raises serious questions about medical evaluations and recovery timelines.
With the deadline only days away, there is little opportunity for Philadelphia’s medical staff to thoroughly assess the hip or project when Buxton might return to form. The Twins themselves face uncertainty about whether this stint will be brief or stretch longer to ensure he is ready for a potential playoff push of their own.
Even if Buxton were healthy, significant obstacles remained. His full no-trade clause and stated loyalty to Minnesota have repeatedly stalled speculation. Ken Rosenthal of The Athletic recently expressed skepticism that the Twins would move him at all, noting the organization’s desire to compete after last year’s selling approach.
The latest injury only reinforces that stance while simultaneously making the player less attractive to contenders. Any trade would now involve taking on not just the remaining years of Buxton’s contract but also the possibility that he contributes little or nothing down the stretch.
The Phillies still need outfield help, particularly a right-handed bat who can handle center field and provide both power and defense. Buxton would have checked every box in theory. In practice, the combination of the hip issue, his extensive injury history, and the compressed timeline before the deadline forces Philadelphia to recalibrate.
Other options remain available on the market, and the front office will almost certainly explore them more aggressively now. Pursuing a player whose availability and effectiveness are suddenly in doubt would represent a high-stakes gamble at a moment when the Phillies are positioning themselves for a deep postseason run.
The injury does not close the door entirely, but it raises the cost of entry and lowers the expected return enough that a deal for Buxton looks far less likely than it did only a few days ago.
